Atlas Trials

Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer

Clinical trial NCT02540824 · UNKNOWN

Trial details

NCT number
NCT02540824
Sponsor
Tongji University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2015-01-01
Primary completion
2016-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.